229 related articles for article (PubMed ID: 26537439)
1. Patient-reported outcomes among patients with type 2 diabetes mellitus treated with dapagliflozin in a triple-therapy regimen for 52 weeks.
Grandy S; Sternhufvud C; Ryden A; Sugg J; Rohwedder K
Diabetes Obes Metab; 2016 Mar; 18(3):306-9. PubMed ID: 26537439
[TBL] [
